Table 1

Baseline and treatment cycle parameters with ovulation dysfunction criteria

Cycle 1: Baseline cycle				Cycle 2: Treatment cycle
Subject	Total cycle length (days)	LF >18 mm		Total cycle length (days)	LF >18 mm, day of medication		LF maximum diameter (mm)	Maximum ES thickness (mm)	*Luteal P level (ng/mL)	Ovulation dysfunction
		LF >18 mm			LF >18 mm, day of medication					Ovulation disruption	LH surge blunted	*Non-ovulatory luteal P	Met >1 ovulation dysfunction criteria
		Cycle day	LH level (IU/L)		Cycle Day	LH level (IU/L)				LF persist >5 days	LH surge blunted	*Non-ovulatory luteal P	Met >1 ovulation dysfunction criteria
01	27	10	8.7	31	10	7.2	24.2	21.6	1.3	Yes	Yes	Yes	Yes
02	32	12	4.4	32	13	18.5	22.9	11.5	5.7	No	Yes	No	Yes
04	29	11	13.6	29	10	6.2	25.7	9.30	6.6	Yes	No	No	Yes
05	34	17	34.8	37	16	14.6	21.0	12.1	1.5	Yes	No	Yes	Yes
06	26	10	13.9	28	10	7.8	23.1	12.8	5.3	No	No	No	No
07	25	9	5.4	34	11	5.7	21.8	12.7	4	Yes	Yes	No	Yes
09	24	9	9.7	27	11	7.9	23.9	9.6	8.8	Yes	Yes	No	Yes
10	32	14	9.8	36	17	10.9	18.9	12.3	3	Yes	No	No	Yes
12	28	10	55.2	31	10	6.80	17.4	11.6	5.4	No	Yes	No	Yes
Mean	28.6	11	17.3	31.9	12	9.5	22.1	12.6	4.6
SD	3.5	2.7	16.8	4.0	2.7	4.4	2.6	3.6	2.4
Median	28.0	10.0	9.8	32.0	11.0	7.8	22.9	12.1	5.3
Range	24–34	9–17	4.4–55.2	27–37	10–17	5.7–18.5	17.4–25.7	9.3–21.6	1.3–8.8

Ovulation dysfunction criteria defined based on established definitions from prior studies.
*Ovulatory luteal phase progesterone level defined as >3.5
ES, endometrial stripe; LF, lead follicle; LH, luteinizing hormone; P, progesterone; SD, standard deviation.